[HTML][HTML] Risk factors and prevention strategies for postoperative opioid abuse

S Zhao, F Chen, A Feng, W Han, Y Zhang - Pain Research and …, 2019 - hindawi.com
Worldwide, 80% of patients who undergo surgery receive opioid analgesics as the
fundamental agent for pain relief. However, the irrational use of opioids leads to excessive …

Pharmacogenetics of OPRM1

RC Crist, WH Berrettini - Pharmacology Biochemistry and Behavior, 2014 - Elsevier
Pharmacogenetic research has the potential to explain the variation in treatment efficacy
within patient populations. Understanding the interaction between genetic variation and …

Endogenous opiates and behavior: 2012

RJ Bodnar - Peptides, 2013 - Elsevier
This paper is the thirty-fifth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2012 …

[HTML][HTML] Introducing precision addiction management of reward deficiency syndrome, the construct that underpins all addictive behaviors

K Blum, MC Gondré-Lewis, D Baron, PK Thanos… - Frontiers in …, 2018 - frontiersin.org
Following almost three decades of genetic-based research related to identifying and
characterizing addiction-related Reward Deficiency Syndrome (RDS), a paradigm shift is …

[HTML][HTML] Mu-opioid receptor-expressing neurons in the paraventricular thalamus modulate chronic morphine-induced wake alterations

D Eacret, E Manduchi, J Noreck, E Tyner… - Translational …, 2023 - nature.com
Disrupted sleep is a symptom of many psychiatric disorders, including substance use
disorders. Most drugs of abuse, including opioids, disrupt sleep. However, the extent and …

[HTML][HTML] Reviewing pharmacogenetics to advance precision medicine for opioids

L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad… - Biomedicine & …, 2021 - Elsevier
Background Adequate opioid prescribing is critical for therapeutic success of pain
management. Despite the widespread use of opioids, optimized opioid therapy remains …

Chronic opioid use and central sleep apnea, where are we now and where to go? A state of the art review

D Wang, BJ Yee, RR Grunstein… - Anesthesia & Analgesia, 2021 - journals.lww.com
Opioids are commonly used for pain management, perioperative procedures, and addiction
treatment. There is a current opioid epidemic in North America that is paralleled by a marked …

The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: a systematic review

IE Bauer, JC Soares, DA Nielsen - The American Journal on …, 2015 - Wiley Online Library
Background and Objectives Drug addiction is a serious illness with deleterious functional
and social consequences for both the affected individuals, their families, and society at …

Pharmacogenetics of opioid use disorder treatment

RC Crist, TK Clarke, WH Berrettini - CNS drugs, 2018 - Springer
Opioid use disorder (OUD) is a significant health problem in the United States and many
other countries. A combination of issues, most notably increased prescription of opioid …

Pharmacogenomics of methadone: a narrative review of the literature

S Packiasabapathy, BW Aruldhas, N Horn… - …, 2020 - Future Medicine
Background: Methadone, a synthetic opioid with longer duration of action and lower abuse
potential compared with morphine, is used to prevent opioid withdrawal, as well as to …